Mangrove Partners’s Acadia Healthcare ACHC Stock Holding History

Mangrove Partners’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,596	Closed	-$363K	–	428
2025 Q4	$363K	Buy	+25,596	New	+$484K	0.03%	184

Other funds holding ACHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mangrove Partners's ACHC Position: Q1 2026 in Review

Mangrove Partners sold out of Acadia Healthcare (ACHC) in Q1 2026, closing a stake of 25,596 shares — an estimated $363K sold.

Mangrove Partners first reported a position in ACHC in Q4 2025 and held it in 1 quarter. The position peaked at $363K in Q4 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

Mangrove Partners reported no remaining Acadia Healthcare position as of Q1 2026 after selling out during the quarter.
Mangrove Partners sold 25,596 Acadia Healthcare shares in Q1 2026, an estimated $363K.
Mangrove Partners first reported a position in Acadia Healthcare in Q4 2025 and held it in 1 quarter.
Mangrove Partners's Acadia Healthcare position peaked at $363K in Q4 2025.
295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Mangrove Partners's 13F filing for Q1 2026, filed 15 May 2026.